APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Ankle Joint Pain Injection

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Ankle Joint Pain Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 173964330322 December 2025195 pages

Choose your research edition.

Industry ResearchAnkle Joint Pain Injection Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Ankle Joint Pain Injection Industry Growth and Trends Forecast to 2032106 pages · $3,450 USDMarket StructureGlobal Ankle Joint Pain Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Ankle Joint Pain Injection Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Ankle Joint Pain Injection Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Ankle Joint Pain Injection market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Ankle Joint Pain Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Ankle Joint Pain Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Ankle Joint Pain Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Ankle Joint Pain Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Ankle Joint Pain Injection include Teva Pharmaceutical Industries, Sanofi S.A, Pfizer, Ferring Pharmaceuticals, Zimmer Biomet Holdings, Wright Medical Group N.V, Seikagaku Corporation, Flexion Therapeutics and Dr. Reddy's Laboratories, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Ankle Joint Pain Injection market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Ankle Joint Pain Injection and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Ankle Joint Pain Injection sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Ankle Joint Pain Injection market size, projected growth trends, production technologies, key applications, and end-use industries.

Ankle Joint Pain Injection Segment by Company

Teva Pharmaceutical Industries

Sanofi S.A

Pfizer

Ferring Pharmaceuticals

Zimmer Biomet Holdings

Wright Medical Group N.V

Seikagaku Corporation

Flexion Therapeutics

Dr. Reddy's Laboratories

Chugai Pharmaceutical

Bioventus

Anika Therapeutics

Ankle Joint Pain Injection Segment by Type

Hyaluronic Acid Injections

Corticosteroid Injections

Platelet Rich Plasma Injections

Others

Ankle Joint Pain Injection Segment by Application

Hospital

Clinic

Others

Ankle Joint Pain Injection Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Ankle Joint Pain Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Ankle Joint Pain Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Ankle Joint Pain Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Ankle Joint Pain Injection market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Ankle Joint Pain Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Ankle Joint Pain Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Ankle Joint Pain Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Ankle Joint Pain Injection Industry Trends Table 2. Ankle Joint Pain Injection Industry Drivers Table 3. Ankle Joint Pain Injection Industry Opportunities and Challenges Table 4. Ankle Joint Pain Injection Industry Restraints Table 5. Global Ankle Joint Pain Injection Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Ankle Joint Pain Injection Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Ankle Joint Pain Injection Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Ankle Joint Pain Injection Sales Market Share by Manufacturers Table 9. Global Ankle Joint Pain Injection Average Sales Price (US$/unit) of Manufacturers (2021-2026) Table 10. Global Ankle Joint Pain Injection Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Ankle Joint Pain Injection Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Ankle Joint Pain Injection Manufacturers, Product Type & Application Table 13. Global Ankle Joint Pain Injection Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Ankle Joint Pain Injection by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Hyaluronic Acid Injections Table 17. Major Manufacturers of Corticosteroid Injections Table 18. Major Manufacturers of Platelet Rich Plasma Injections Table 19. Major Manufacturers of Others Table 20. Global Ankle Joint Pain Injection Sales by Type 2021 VS 2025 VS 2032 (k units) Table 21. Global Ankle Joint Pain Injection Sales by Type (2021-2026) & (k units) Table 22. Global Ankle Joint Pain Injection Sales by Type (2027-2032) & (k units) Table 23. Global Ankle Joint Pain Injection Sales Market Share by Type (2021-2026) Table 24. Global Ankle Joint Pain Injection Sales Market Share by Type (2027-2032) Table 25. Global Ankle Joint Pain Injection Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 26. Global Ankle Joint Pain Injection Revenue by Type (2021-2026) & (k units) Table 27. Global Ankle Joint Pain Injection Revenue by Type (2027-2032) & (k units) Table 28. Global Ankle Joint Pain Injection Revenue Market Share by Type (2021-2026) Table 29. Global Ankle Joint Pain Injection Revenue Market Share by Type (2027-2032) Table 30. Major Manufacturers of Hospital Table 31. Major Manufacturers of Clinic Table 32. Major Manufacturers of Others Table 33. Global Ankle Joint Pain Injection Sales by Application 2021 VS 2025 VS 2032 (k units) Table 34. Global Ankle Joint Pain Injection Sales by Application (2021-2026) & (k units) Table 35. Global Ankle Joint Pain Injection Sales by Application (2027-2032) & (k units) Table 36. Global Ankle Joint Pain Injection Sales Market Share by Application (2021-2026) Table 37. Global Ankle Joint Pain Injection Sales Market Share by Application (2027-2032) Table 38. Global Ankle Joint Pain Injection Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 39. Global Ankle Joint Pain Injection Revenue by Application (2021-2026) & (k units) Table 40. Global Ankle Joint Pain Injection Revenue by Application (2027-2032) & (k units) Table 41. Global Ankle Joint Pain Injection Revenue Market Share by Application (2021-2026) Table 42. Global Ankle Joint Pain Injection Revenue Market Share by Application (2027-2032) Table 43. Global Ankle Joint Pain Injection Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 44. Global Ankle Joint Pain Injection Sales by Region (2021-2026) & (k units) Table 45. Global Ankle Joint Pain Injection Sales Market Share by Region (2021-2026) Table 46. Global Ankle Joint Pain Injection Sales Forecasted by Region (2027-2032) & (k units) Table 47. Global Ankle Joint Pain Injection Sales Forecasted Market Share by Region (2027-2032) Table 48. North America Ankle Joint Pain Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 49. North America Ankle Joint Pain Injection Sales by Country (2021-2026) & (k units) Table 50. North America Ankle Joint Pain Injection Sales by Country (2027-2032) & (k units) Table 51. Europe Ankle Joint Pain Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 52. Europe Ankle Joint Pain Injection Sales by Country (2021-2026) & (k units) Table 53. Europe Ankle Joint Pain Injection Sales by Country (2027-2032) & (k units) Table 54. Asia Pacific Ankle Joint Pain Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 55. Asia Pacific Ankle Joint Pain Injection Sales by Country (2021-2026) & (k units) Table 56. Asia Pacific Ankle Joint Pain Injection Sales by Country (2027-2032) & (k units) Table 57. South America, Middle East and Africa Ankle Joint Pain Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 58. South America, Middle East and Africa Ankle Joint Pain Injection Sales by Country (2021-2026) & (k units) Table 59. South America, Middle East and Africa Ankle Joint Pain Injection Sales by Country (2027-2032) & (k units) Table 60. Global Ankle Joint Pain Injection Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 61. Global Ankle Joint Pain Injection Revenue by Region (2021-2026) & (US$ Million) Table 62. Global Ankle Joint Pain Injection Revenue by Region (2027-2032) & (US$ Million) Table 63. Global Ankle Joint Pain Injection Revenue Market Share by Region (2021-2026) Table 64. Global Ankle Joint Pain Injection Revenue Market Share by Region (2027-2032) Table 65. Teva Pharmaceutical Industries Company Information Table 66. Teva Pharmaceutical Industries Business Overview Table 67. Teva Pharmaceutical Industries Ankle Joint Pain Injection Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Teva Pharmaceutical Industries Ankle Joint Pain Injection Product Portfolio Table 69. Teva Pharmaceutical Industries Recent Development Table 70. Sanofi S.A Company Information Table 71. Sanofi S.A Business Overview Table 72. Sanofi S.A Ankle Joint Pain Injection Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Sanofi S.A Ankle Joint Pain Injection Product Portfolio Table 74. Sanofi S.A Recent Development Table 75. Pfizer Company Information Table 76. Pfizer Business Overview Table 77. Pfizer Ankle Joint Pain Injection Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Pfizer Ankle Joint Pain Injection Product Portfolio Table 79. Pfizer Recent Development Table 80. Ferring Pharmaceuticals Company Information Table 81. Ferring Pharmaceuticals Business Overview Table 82. Ferring Pharmaceuticals Ankle Joint Pain Injection Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Ferring Pharmaceuticals Ankle Joint Pain Injection Product Portfolio Table 84. Ferring Pharmaceuticals Recent Development Table 85. Zimmer Biomet Holdings Company Information Table 86. Zimmer Biomet Holdings Business Overview Table 87. Zimmer Biomet Holdings Ankle Joint Pain Injection Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Zimmer Biomet Holdings Ankle Joint Pain Injection Product Portfolio Table 89. Zimmer Biomet Holdings Recent Development Table 90. Wright Medical Group N.V Company Information Table 91. Wright Medical Group N.V Business Overview Table 92. Wright Medical Group N.V Ankle Joint Pain Injection Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 93. Wright Medical Group N.V Ankle Joint Pain Injection Product Portfolio Table 94. Wright Medical Group N.V Recent Development Table 95. Seikagaku Corporation Company Information Table 96. Seikagaku Corporation Business Overview Table 97. Seikagaku Corporation Ankle Joint Pain Injection Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 98. Seikagaku Corporation Ankle Joint Pain Injection Product Portfolio Table 99. Seikagaku Corporation Recent Development Table 100. Flexion Therapeutics Company Information Table 101. Flexion Therapeutics Business Overview Table 102. Flexion Therapeutics Ankle Joint Pain Injection Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 103. Flexion Therapeutics Ankle Joint Pain Injection Product Portfolio Table 104. Flexion Therapeutics Recent Development Table 105. Dr. Reddy's Laboratories Company Information Table 106. Dr. Reddy's Laboratories Business Overview Table 107. Dr. Reddy's Laboratories Ankle Joint Pain Injection Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 108. Dr. Reddy's Laboratories Ankle Joint Pain Injection Product Portfolio Table 109. Dr. Reddy's Laboratories Recent Development Table 110. Chugai Pharmaceutical Company Information Table 111. Chugai Pharmaceutical Business Overview Table 112. Chugai Pharmaceutical Ankle Joint Pain Injection Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 113. Chugai Pharmaceutical Ankle Joint Pain Injection Product Portfolio Table 114. Chugai Pharmaceutical Recent Development Table 115. Bioventus Company Information Table 116. Bioventus Business Overview Table 117. Bioventus Ankle Joint Pain Injection Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 118. Bioventus Ankle Joint Pain Injection Product Portfolio Table 119. Bioventus Recent Development Table 120. Anika Therapeutics Company Information Table 121. Anika Therapeutics Business Overview Table 122. Anika Therapeutics Ankle Joint Pain Injection Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 123. Anika Therapeutics Ankle Joint Pain Injection Product Portfolio Table 124. Anika Therapeutics Recent Development Table 125. Key Raw Materials Table 126. Raw Materials Key Suppliers Table 127. Ankle Joint Pain Injection Distributors List Table 128. Ankle Joint Pain Injection Customers List Table 129. Research Programs/Design for This Report Table 130. Authors List of This Report Table 131. Secondary Sources Table 132. Primary Sources List of Figures Figure 1. Ankle Joint Pain Injection Product Image Figure 2. Global Ankle Joint Pain Injection Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Ankle Joint Pain Injection Market Size (2021-2032) & (US$ Million) Figure 4. Global Ankle Joint Pain Injection Sales (2021-2032) & (k units) Figure 5. Global Ankle Joint Pain Injection Average Price (US$/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Ankle Joint Pain Injection Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Hyaluronic Acid Injections Image Figure 9. Corticosteroid Injections Image Figure 10. Platelet Rich Plasma Injections Image Figure 11. Others Image Figure 12. Global Ankle Joint Pain Injection Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 13. Global Ankle Joint Pain Injection Sales Market Share 2021 VS 2025 VS 2032 Figure 14. Global Ankle Joint Pain Injection Sales Market Share by Type (2021-2032) Figure 15. Global Ankle Joint Pain Injection Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 16. Global Ankle Joint Pain Injection Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Ankle Joint Pain Injection Revenue Market Share by Type (2021-2032) Figure 18. Hospital Image Figure 19. Clinic Image Figure 20. Others Image Figure 21. Global Ankle Joint Pain Injection Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 22. Global Ankle Joint Pain Injection Sales Market Share 2021 VS 2025 VS 2032 Figure 23. Global Ankle Joint Pain Injection Sales Market Share by Application (2021-2032) Figure 24. Global Ankle Joint Pain Injection Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 25. Global Ankle Joint Pain Injection Revenue Market Share 2021 VS 2025 VS 2032 Figure 26. Global Ankle Joint Pain Injection Revenue Market Share by Application (2021-2032) Figure 27. North America Ankle Joint Pain Injection Sales and Growth Rate (2021-2032) & (k units) Figure 28. North America Ankle Joint Pain Injection Sales Market Share by Country (2021-2032) Figure 29. U.S. Ankle Joint Pain Injection Sales and Growth Rate (2021-2032) & (k units) Figure 30. Canada Ankle Joint Pain Injection Sales and Growth Rate (2021-2032) & (k units) Figure 31. Mexico Ankle Joint Pain Injection Sales and Growth Rate (2021-2032) & (k units) Figure 32. Europe Ankle Joint Pain Injection Sales and Growth Rate (2021-2032) & (k units) Figure 33. Europe Ankle Joint Pain Injection Sales Market Share by Country (2021-2032) Figure 34. Germany Ankle Joint Pain Injection Sales and Growth Rate (2021-2032) & (k units) Figure 35. France Ankle Joint Pain Injection Sales and Growth Rate (2021-2032) & (k units) Figure 36. U.K. Ankle Joint Pain Injection Sales and Growth Rate (2021-2032) & (k units) Figure 37. Italy Ankle Joint Pain Injection Sales and Growth Rate (2021-2032) & (k units) Figure 38. Netherlands Ankle Joint Pain Injection Sales and Growth Rate (2021-2032) & (k units) Figure 39. Asia Pacific Ankle Joint Pain Injection Sales and Growth Rate (2021-2032) & (k units) Figure 40. Asia Pacific Ankle Joint Pain Injection Sales Market Share by Country (2021-2032) Figure 41. China Ankle Joint Pain Injection Sales and Growth Rate (2021-2032) & (k units) Figure 42. Japan Ankle Joint Pain Injection Sales and Growth Rate (2021-2032) & (k units) Figure 43. South Korea Ankle Joint Pain Injection Sales and Growth Rate (2021-2032) & (k units) Figure 44. Southeast Asia Ankle Joint Pain Injection Sales and Growth Rate (2021-2032) & (k units) Figure 45. India Ankle Joint Pain Injection Sales and Growth Rate (2021-2032) & (k units) Figure 46. Australia Ankle Joint Pain Injection Sales and Growth Rate (2021-2032) & (k units) Figure 47. South America, Middle East and Africa Ankle Joint Pain Injection Sales and Growth Rate (2021-2032) & (k units) Figure 48. South America, Middle East and Africa Ankle Joint Pain Injection Sales Market Share by Country (2021-2032) Figure 49. Brazil Ankle Joint Pain Injection Sales and Growth Rate (2021-2032) & (k units) Figure 50. South Africa Ankle Joint Pain Injection Sales and Growth Rate (2021-2032) & (k units) Figure 51. Saudi Arabia Ankle Joint Pain Injection Sales and Growth Rate (2021-2032) & (k units) Figure 52. Turkey Ankle Joint Pain Injection Sales and Growth Rate (2021-2032) & (k units) Figure 53. Argentina Ankle Joint Pain Injection Sales and Growth Rate (2021-2032) & (k units) Figure 54. UAE Ankle Joint Pain Injection Sales and Growth Rate (2021-2032) & (k units) Figure 55. Egypt Ankle Joint Pain Injection Sales and Growth Rate (2021-2032) & (k units) Figure 56. Chile Ankle Joint Pain Injection Sales and Growth Rate (2021-2032) & (k units) Figure 57. Global Ankle Joint Pain Injection Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Global Ankle Joint Pain Injection Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 59. North America Ankle Joint Pain Injection Revenue (2021-2032) & (US$ Million) Figure 60. North America Ankle Joint Pain Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Europe Ankle Joint Pain Injection Revenue (2021-2032) & (US$ Million) Figure 62. Europe Ankle Joint Pain Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. Asia-Pacific Ankle Joint Pain Injection Revenue (2021-2032) & (US$ Million) Figure 64. Asia-Pacific Ankle Joint Pain Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. South America, Middle East and Africa Ankle Joint Pain Injection Revenue (2021-2032) & (US$ Million) Figure 66. South America, Middle East and Africa Ankle Joint Pain Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. Ankle Joint Pain Injection Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Ankle Joint Pain Injection Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Hyaluronic Acid Injections
  • Corticosteroid Injections
  • Platelet Rich Plasma Injections
  • Others
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Teva Pharmaceutical Industries
  • Sanofi S.A
  • Pfizer
  • Ferring Pharmaceuticals
  • Zimmer Biomet Holdings
  • Wright Medical Group N.V
  • Seikagaku Corporation
  • Flexion Therapeutics
  • Dr. Reddy's Laboratories
  • Chugai Pharmaceutical
  • Bioventus
  • Anika Therapeutics

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Ankle Joint Pain Injection Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Ankle Joint Pain Injection Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Ankle Joint Pain Injection Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Ankle Joint Pain Injection Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Ankle Joint Pain Injection Market Dynamics
  1. 2.1 Ankle Joint Pain Injection Industry Trends
  2. 2.2 Ankle Joint Pain Injection Industry Drivers
  3. 2.3 Ankle Joint Pain Injection Industry Opportunities and Challenges
  4. 2.4 Ankle Joint Pain Injection Industry Restraints
3 Ankle Joint Pain Injection Market by Manufacturers
  1. 3.1 Global Ankle Joint Pain Injection Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Ankle Joint Pain Injection Sales by Manufacturers (2021-2026)
  3. 3.3 Global Ankle Joint Pain Injection Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Ankle Joint Pain Injection Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Ankle Joint Pain Injection Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Ankle Joint Pain Injection Manufacturers, Product Type & Application
  7. 3.7 Global Ankle Joint Pain Injection Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Ankle Joint Pain Injection Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Ankle Joint Pain Injection Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Ankle Joint Pain Injection Tier 1, Tier 2, and Tier 3
4 Ankle Joint Pain Injection Market by Type
  1. 4.1 Ankle Joint Pain Injection Type Introduction
  2. 4.1.1 Hyaluronic Acid Injections
  3. 4.1.2 Corticosteroid Injections
  4. 4.1.3 Platelet Rich Plasma Injections
  5. 4.1.4 Others
  6. 4.2 Global Ankle Joint Pain Injection Sales by Type
  7. 4.2.1 Global Ankle Joint Pain Injection Sales by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Ankle Joint Pain Injection Sales by Type (2021-2032)
  9. 4.2.3 Global Ankle Joint Pain Injection Sales Market Share by Type (2021-2032)
  10. 4.3 Global Ankle Joint Pain Injection Revenue by Type
  11. 4.3.1 Global Ankle Joint Pain Injection Revenue by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Ankle Joint Pain Injection Revenue by Type (2021-2032)
  13. 4.3.3 Global Ankle Joint Pain Injection Revenue Market Share by Type (2021-2032)
5 Ankle Joint Pain Injection Market by Application
  1. 5.1 Ankle Joint Pain Injection Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Others
  5. 5.2 Global Ankle Joint Pain Injection Sales by Application
  6. 5.2.1 Global Ankle Joint Pain Injection Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Ankle Joint Pain Injection Sales by Application (2021-2032)
  8. 5.2.3 Global Ankle Joint Pain Injection Sales Market Share by Application (2021-2032)
  9. 5.3 Global Ankle Joint Pain Injection Revenue by Application
  10. 5.3.1 Global Ankle Joint Pain Injection Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Ankle Joint Pain Injection Revenue by Application (2021-2032)
  12. 5.3.3 Global Ankle Joint Pain Injection Revenue Market Share by Application (2021-2032)
6 Global Ankle Joint Pain Injection Sales by Region
  1. 6.1 Global Ankle Joint Pain Injection Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Ankle Joint Pain Injection Sales by Region (2021-2032)
  3. 6.2.1 Global Ankle Joint Pain Injection Sales by Region (2021-2026)
  4. 6.2.2 Global Ankle Joint Pain Injection Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Ankle Joint Pain Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Ankle Joint Pain Injection Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Ankle Joint Pain Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Ankle Joint Pain Injection Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Ankle Joint Pain Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Ankle Joint Pain Injection Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Ankle Joint Pain Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Ankle Joint Pain Injection Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Ankle Joint Pain Injection Revenue by Region
  1. 7.1 Global Ankle Joint Pain Injection Revenue by Region
  2. 7.1.1 Global Ankle Joint Pain Injection Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Ankle Joint Pain Injection Revenue by Region (2021-2026)
  4. 7.1.3 Global Ankle Joint Pain Injection Revenue by Region (2027-2032)
  5. 7.1.4 Global Ankle Joint Pain Injection Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Ankle Joint Pain Injection Revenue (2021-2032)
  8. 7.2.2 North America Ankle Joint Pain Injection Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Ankle Joint Pain Injection Revenue (2021-2032)
  11. 7.3.2 Europe Ankle Joint Pain Injection Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Ankle Joint Pain Injection Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Ankle Joint Pain Injection Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Ankle Joint Pain Injection Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Ankle Joint Pain Injection Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Teva Pharmaceutical Industries
  2. 8.1.1 Teva Pharmaceutical Industries Company Information
  3. 8.1.2 Teva Pharmaceutical Industries Business Overview
  4. 8.1.3 Teva Pharmaceutical Industries Ankle Joint Pain Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Teva Pharmaceutical Industries Ankle Joint Pain Injection Product Portfolio
  6. 8.1.5 Teva Pharmaceutical Industries Recent Developments
  7. 8.2 Sanofi S.A
  8. 8.2.1 Sanofi S.A Company Information
  9. 8.2.2 Sanofi S.A Business Overview
  10. 8.2.3 Sanofi S.A Ankle Joint Pain Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Sanofi S.A Ankle Joint Pain Injection Product Portfolio
  12. 8.2.5 Sanofi S.A Recent Developments
  13. 8.3 Pfizer
  14. 8.3.1 Pfizer Company Information
  15. 8.3.2 Pfizer Business Overview
  16. 8.3.3 Pfizer Ankle Joint Pain Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Pfizer Ankle Joint Pain Injection Product Portfolio
  18. 8.3.5 Pfizer Recent Developments
  19. 8.4 Ferring Pharmaceuticals
  20. 8.4.1 Ferring Pharmaceuticals Company Information
  21. 8.4.2 Ferring Pharmaceuticals Business Overview
  22. 8.4.3 Ferring Pharmaceuticals Ankle Joint Pain Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Ferring Pharmaceuticals Ankle Joint Pain Injection Product Portfolio
  24. 8.4.5 Ferring Pharmaceuticals Recent Developments
  25. 8.5 Zimmer Biomet Holdings
  26. 8.5.1 Zimmer Biomet Holdings Company Information
  27. 8.5.2 Zimmer Biomet Holdings Business Overview
  28. 8.5.3 Zimmer Biomet Holdings Ankle Joint Pain Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Zimmer Biomet Holdings Ankle Joint Pain Injection Product Portfolio
  30. 8.5.5 Zimmer Biomet Holdings Recent Developments
  31. 8.6 Wright Medical Group N.V
  32. 8.6.1 Wright Medical Group N.V Company Information
  33. 8.6.2 Wright Medical Group N.V Business Overview
  34. 8.6.3 Wright Medical Group N.V Ankle Joint Pain Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Wright Medical Group N.V Ankle Joint Pain Injection Product Portfolio
  36. 8.6.5 Wright Medical Group N.V Recent Developments
  37. 8.7 Seikagaku Corporation
  38. 8.7.1 Seikagaku Corporation Company Information
  39. 8.7.2 Seikagaku Corporation Business Overview
  40. 8.7.3 Seikagaku Corporation Ankle Joint Pain Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Seikagaku Corporation Ankle Joint Pain Injection Product Portfolio
  42. 8.7.5 Seikagaku Corporation Recent Developments
  43. 8.8 Flexion Therapeutics
  44. 8.8.1 Flexion Therapeutics Company Information
  45. 8.8.2 Flexion Therapeutics Business Overview
  46. 8.8.3 Flexion Therapeutics Ankle Joint Pain Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Flexion Therapeutics Ankle Joint Pain Injection Product Portfolio
  48. 8.8.5 Flexion Therapeutics Recent Developments
  49. 8.9 Dr. Reddy's Laboratories
  50. 8.9.1 Dr. Reddy's Laboratories Company Information
  51. 8.9.2 Dr. Reddy's Laboratories Business Overview
  52. 8.9.3 Dr. Reddy's Laboratories Ankle Joint Pain Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Dr. Reddy's Laboratories Ankle Joint Pain Injection Product Portfolio
  54. 8.9.5 Dr. Reddy's Laboratories Recent Developments
  55. 8.10 Chugai Pharmaceutical
  56. 8.10.1 Chugai Pharmaceutical Company Information
  57. 8.10.2 Chugai Pharmaceutical Business Overview
  58. 8.10.3 Chugai Pharmaceutical Ankle Joint Pain Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Chugai Pharmaceutical Ankle Joint Pain Injection Product Portfolio
  60. 8.10.5 Chugai Pharmaceutical Recent Developments
  61. 8.11 Bioventus
  62. 8.11.1 Bioventus Company Information
  63. 8.11.2 Bioventus Business Overview
  64. 8.11.3 Bioventus Ankle Joint Pain Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Bioventus Ankle Joint Pain Injection Product Portfolio
  66. 8.11.5 Bioventus Recent Developments
  67. 8.12 Anika Therapeutics
  68. 8.12.1 Anika Therapeutics Company Information
  69. 8.12.2 Anika Therapeutics Business Overview
  70. 8.12.3 Anika Therapeutics Ankle Joint Pain Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Anika Therapeutics Ankle Joint Pain Injection Product Portfolio
  72. 8.12.5 Anika Therapeutics Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Ankle Joint Pain Injection Value Chain Analysis
  2. 9.1.1 Ankle Joint Pain Injection Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Ankle Joint Pain Injection Production Mode & Process
  6. 9.2 Ankle Joint Pain Injection Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Ankle Joint Pain Injection Distributors
  9. 9.2.3 Ankle Joint Pain Injection Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst